Low density lipoprotein particle size and risk factors of insulin resistance syndrome

Atherosclerosis

Volumn 148, Issue 1, 2000, Pages 141-149

  Friedlander, Yechiel ^a   Kidron, Miriam ^b   Caslake, Muriel ^c   Lamb, Tracey ^c   McConnell, Michael ^c   Bar On, Hanoch ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Insulin resistance; LDL subclass; Lipids; Lipoproteins

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PARTICLE SIZE; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PARTICLE SIZE; REFERENCE VALUES; RISK FACTORS; SYNDROME; TRIGLYCERIDES;

EID: 0033990515     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00215-4     Document Type: Article

References (57)

1. Crouse J.R., Parks J.S., Schey H.M. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J. Lipid Res. 26:1985;566-574.
2. Austin M.A., Breslow J.L., Hennekens C.H., Buring J.E., Willett W.S., Krauss R.M. Low-density lipoprotein subclass patterns and risk of myocardial infarction. J. Am. Med. Assoc. 260:1988;1917-1921.
3. Campos H., Genest J.J., Blijlevens E., McNamara J.R., Jenner J.L., Ordovas J.M., Wilson P.W.F., Schaefer E.J. Low density lipoprotein particle size and coronary artery disease. Arterioscler. Thromb. 12:1992;187-195.
4. Gardner C.D., Fortmann S.P., Krauss R.M. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. J. Am. Med. Assoc. 276:1996;875-881.
5. Stampfer M.J., Krauss R.M., Ma J., Blanche P.J., Holl L.G., Sacks F.M., Hennekens C.H. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. J. Am. Med. Assoc. 276:1996;882-888.
6. Lamarche B., Tchernof A., Moorjani S., Cantin B., Dagenais G.R., Lupien P.J., Despres J.-P. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Circulation. 95:1997;69-75.
7. Swinkels D.W.L., Demacker P.N.M., Hendriks J.C.M., van't Laar A. Low density lipoprotein subfraction and relationship to other risk factors for coronary artery disease in healthy individuals. Arteriosclerosis. 9:1989;904-913.
8. Austin M.A., King M.-C., Vranzian K.M., Krauss R.M. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation. 82:1990;495-506.
9. McNamara J.R., Jenner J.L., Li Z., Wilson P.W.F., Schafer E.J. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler. Thromb. 12:1992;1284-1290.
10. Haffner S.M., Mtkkanen L., Valdez R.A., Paidi M., Stern M.P., Howard B.V. LDL size and subclass pattern in a biethnic population. Arterioscler. Thromb. 13:1993;1628-1630.
11. Stout R.W. Insulin and atheroma: 20-yr prespective. Diabetes Care. 13:1990;631-654.
12. Eschwege E., Richard J.L., Thibult N., Ducimetiere P., Warnet J.M., Claude J.R., Rosselin G. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: the Paris Prospective Study, 10 years later. Horm. Metab. Res. Suppl. 15:1985;41-46.
13. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland. Diabetes Care. 2:1979;131-141.
14. Pyorala K., Savolainen E., Kaukola S., Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2 year follow-up of the Helsinki Policemen Study Population. Acta Med. Scand. (Suppl.). 701:1985;38-52.
15. Ducimetiere P., Eschwege E., Papoz L., Richard J.L., Claude J.R., Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia. 19:1980;205-210.
16. Welborn T.A., Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 2:1979;154-160.
17. Cullen K., Stenhouse N.S., Wearne K.L., Welborn T.A. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Basselton, Western Australia - 13-year study. J. Chron. Dis. 36:1983;371-377.
18. Hargreaves A.D., Logan R.L., Elton R.A., Buchanan K.D., Oliver M.F., Riemersma R.A. Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men. Atherosclerosis. 94:1992;61-69.
19. Yarnell J.W., Sweetnam P.M., Marks V., Teale J.D., Bolton C.H. Insulin in ischaemic heart disease: are associations explained by triglyceride concentrations? The Caerphilly prospective study. Br. Heart J. 71:1994;293-296.
20. Orchard T.J., Eichner J., Kuller L.H., Becker D.J., McCallum L.M., Grandits G.A. Insulin as a predictor of coronary heart disease: interaction with apolipoprotein E phenotype: a report from the Multiple Risk Factor Intervention Trial. Ann. Epidemiol. 4:1994;40-45.
21. Reaven G.M. Role of insulin resistance in human disease. Banting lecture 1988. Diabetes. 37:1988;1595-1607.
22. Barakat H.A., Carpenter J.W., McLendon V.D., Khazanie P., Legget N., Heath J., Marks R. Influence of obesity, impared glucose tolerance, and NIDDM on LDL structure and composition: possible link between hyperinsulinemia and atherosclerosis. Diabetes. 39:1990;1527-1533.
23. Barakat H.A., Marks R. Association of small LDL particles with hyperinsulinemia. Arteriosclerosis. 9:1989;725a.
24. Selby J.V., Austin M.A., Newman B., Zhang D., Quesenberry C.P., Mayer E.J., Krauss R.M. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation. 88:1993;381-387.
25. Reaven G.M., Chen Y.-D.I., Jeppesen J., Maheux P., Krauss R.M. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J. Clin. Invest. 92:1993;141-146.
26. Haffner S.M., Mykkanen L., Robbins D., Valdez R., Miettinen H., Howard B.V., Stern M.P., Bowsher R. Preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects. Diabetologia. 38:1995;1328-1336.
27. Terry R.B., Wood P.D., Haskell W.L., Stefanick M.L., Krauss R.M. Regional adiposity pattern in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men. Clin. Endocrinol. Metab. 68:1989;191-199.
28. Bar-On H., Friedlander Y., Kidron M., Kark J.D. Serum glucose and insulin characteristics and prevalence of diabetes mellitus and impaired glucose tolerance in adult Jewish population of Jerusalem. The Jerusalem Diabetes Prevalence Study. Nutr. Metab. Cardiovasc. Dis. 2:1992;75-81.
29. Friedwald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma-without use of preparative ultracentrifuge. Clin. Chem. 18:1972;449-502.
30. Friedlander Y., Kark J.D., Eisenberg S., Stein Y. Calculation of LDL-cholesterol from total cholesterol, triglyceride and HDL-cholesterol: a comparison of methods in the Jerusalem Lipid Research Clinic prevalence study. Isr. J. Med. Sci. 18:1982;1242-1252.
31. Nichols A.V., Krauss R.M., Musliner T.A. Non-denaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 128:1982;417-431.
32. Griffin B.A., Caslake M.J., Yip B., Tait G.W., Packard C.J., Shepherd J. Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis. 83:1990;59-67.
33. Karlin S., Carmelli D., Williams P.T., Friedlander Y., Colen T., Stein Y. Association of arrays for comparing familial total cholesterol, high density lipoprotein cholesterol, and triglyceride similarity in the Israeli population by country of origin. Am. J. Epidemiol. 116:1982;1022-1032.
34. Karlin S. The method of association arrays in assessing forms of dependencies between bivariate random variables. Proc. Natl. Acad. Sci. USA. 80:1983;647-651.
35. Hollenbeck C., Reaven G.M. Variations in insulin-stimulated glucose uptake in individuals with normal glucose tolerance. J. Clin. Endocrinol. Metab. 64:1987;1169-1173.
36. Laakso M. How good a marker is insulin level for insulin resistance? Am. J. Epidemiol. 137:1993;959-965.
37. Saad M.F., Anderson R.L., Laws A., Watanabe R.M., Kades W.W., Chen Y.D.I., Sands R.E., Pei D., Savage P.H., Bergman R.N. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes. 43:1994;1114-1121.
38. Austin M.A., Selby J.V. LDL subclass phenotypes and the risk factors of the insulin resistance syndrome. Int. J. Obes. 19(Suppl. 1):1995;S22-S26.
39. Mykkanen L., Haffner S.M., Rainwater D.L., Karhapaa P., Miettinen H., Laakso M. Relationship of LDL size to insulin sensitivity in normoglycemic men. Arterioscler. Thromb. Vasc. Biol. 17:1997;1447-1453.
40. Slyper A.H., Zvereva S., Schectman G., Hoffmann R.G., Mueller R.A., Walker J.A. Insulin resistance is not a major determinant of low-density lipoprotein particle size. Metabolism. 46:1997;1275-1280.
41. Gray R.S., Robbins D.C., Wang W., Yeh J.L., Fabsitz R.R., Cowan L.D., Welty T.K., Lee E.T., Krauss R.M., Howard B.V. Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study. Arterioscler. Thromb. Vasc. Biol. 17:1997;2713-2720.
42. Ambrosch A., Muhlen I., Kopf D., Augustin W., Dierkes J., Konig W., Luley C., Lehnert H. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and health subjects. Diabetes Care. 21:1998;2077-2084.
43. Tchernof A., Lamarche B., Prud'homme D., Nadeau A., Moorjani S., Labrie F., Lupien P.J., Despres J.-P. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care. 19:1996;629-637.
44. Slyper A.H., Zvereva S., Schectman G., Hoffmann R.G., Mueller R.A., Walker J.A. Insulin resistance is not a major determinant of low-density lipoprotein particle size. Metabolism. 46:1997;1275-1280.
45. Austin M.A. Low density lipoprotein subclass phenotypes. Goldbourt U., de Faire U., Berg K. Genetic Factors in Coronary Heart Disease. 1994;105-113 Kluwer Academic, London.
46. Reaven G.M., Lerner R.L., Stern M.P., Farquhar J.W. Role of insulin in endogenous hypertriglyceridemia. J. Clin. Invest. 46:1967;1756-1767.
47. Tobey T.A., Greenfield M.S., Kraemer F., Reaven G.M. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism. 30:1981;165-171.
48. Reaven G.M. Abnormal lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Athogenesis and treatment. Am. J. Med. 83(Suppl. 3A):1987;31-40.
49. Austin M.A., Hokanson J.E., Edwards K.L. Hypertriglyceridemia as a cardivascular risk factor. Am. J. Cardiol. 81(4A):1998;7B-12B.
50. Fontbonne A.M., Eschwege E.M. Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care. 14:1991;461-469.
51. Castelli W.P. The triglyceride issue: a view from Framingham. Am. Heart. J. 112:1986;432-437.
52. McNamara J.R., Campos H., Ordovas J.M., Peterson J., Wilson P.W.F., Schaefer E.J. Effect of gender,age, and lipid status on low density lipoprotein subfraction distribution: results from the Framingham Offspring Study. Arteriosclerosis. 7:1987;484-490.
53. Austin M.A., Brunzell J.D., Fitch W.L., Krauss R.M. Inheritance of low density lipoprotein subclass pattern in familial combined hyperlipidemia. Arteriosclerosis. 10:1990;520-530.
54. Campos H., Genest J.J., Blijlevens E., McNamara J.R., Ordovas J.M., Posner B.M., Wilson P.W.F., Castelli W.P., Schaefer E.J. LDL particle distribution. Results from the Framingham Offspring Study. Arterioscler. Thromb. 12:1992;1410-1419.
55. Williams P.T., Krauss R.M., Vranizan K.M., Wood P.D.S. Changes in lipoprotein subfraction during diet-induced and exercise-induced weight loss in moderately overweight men. Circulation. 81:1990;1293-1304.
56. Dreon D.M., Fernstrom H.A., Miller B., Krauss R.M. Low-density lipoprotein subclass pattern and lipoprotein response to a reduced-fat diet in men. FASEB J. 8:1994;121-126.
57. Superko H.R., Krauss R.M. Differential effects of nicotinic acid in subjects with different LDL subclass patterns. Atherosclerosis. 95:1992;69-76.